Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Notes Payables (2016 - 2025)

Greater Cannabis Company has reported Notes Payables over the past 7 years, most recently at $243437.0 for Q4 2022.

  • For Q4 2022, Notes Payables fell 34.04% year-over-year to $243437.0; the TTM value through Dec 2022 reached $243437.0, down 34.04%, while the annual FY2022 figure was $243437.0, 34.04% down from the prior year.
  • Notes Payables for Q4 2022 was $243437.0 at Greater Cannabis Company, up from $135000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $467437.0 in Q1 2022 and troughed at $22500.0 in Q1 2021.
  • A 5-year average of $199724.3 and a median of $165350.0 in 2020 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: crashed 86.39% in 2021 and later surged 1977.5% in 2022.
  • Year by year, Notes Payables stood at $65917.0 in 2018, then surged by 505.79% to $399318.0 in 2019, then decreased by 18.56% to $325212.0 in 2020, then increased by 13.49% to $369095.0 in 2021, then plummeted by 34.04% to $243437.0 in 2022.
  • Business Quant data shows Notes Payables for GCAN at $243437.0 in Q4 2022, $135000.0 in Q3 2022, and $25000.0 in Q2 2022.